TMBR
+0.74%(+0.00)
Open
0.34
Prev Close
0.34
Day High
0.35
Day Low
0.32
Volume
130,464
Avg Volume
107,900
52W High
3.39
52W Low
0.32
ANALYST COVERAGE1 analysts
HOLD
Hold
1100%
0 Buy (0%)1 Hold (100%)0 Sell (0%)
Full report →
Key MetricsTTM
Market Cap$1.18M
Revenue TTM$83.2K
Net Income TTM-$15.05M
Free Cash Flow-$13.89M
Gross Margin-15892.4%
Operating Margin-23125.9%
Net Margin-23299.0%
Return on Equity-209.5%
Return on Assets-188.6%
Debt / Equity0.06
Current Ratio1.95
EPS TTM$-9.19
PRICE
Prev Close
0.34
Open
0.34
Day Range0.32 – 0.35
0.32
0.35
52W Range0.32 – 3.39
0.32
3.39
1% of range
VOLUME & SIZE
Avg Volume
107.9K
FUNDAMENTALS
P/E Ratio
-0.2x
Not profitable
EPS (TTM)
Div Yield
No dividend
TECHNICAL
RSI (14)
100
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 167 days
Nov 6

TMBR News

About

timber pharmaceuticals llc, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. the company was founded in 2019 and is based in woodcliff lake, new jersey.

Industry
Medicinal and Botanical Manufacturing
John KoconisChairman, Chief Executive Officer & President
Joseph LuccheseExecutive Vice President, Chief Financial Officer, Treasurer & Secretary